← Back to Search

Procedure

Nerve Block for Brain Aneurysm Bleeding

Q: What is the total number of participants currently enrolled in this investigation?

<p>Affirmative. Clinicaltrials.gov divulges that this trial is actively accepting participants with the initial annoucement of posting dated on November 6th 2023 and most recent update occurring on November 3rd 232023. The study requires 10 individuals to be enrolled from 1 medical site.</p>

Q: Are opportunities available to join this investigation currently?

<p>The clinical trial registry on ClinicalTrials.gov verifies that the medical study is currently enrolling participants. This research project was initiated in November 6th 2023 and was revised most recently on November 3rd of the same year.</p>

Phase < 1

Recruiting

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aneurysmal subarachnoid hemorrhage with secured aneurysm

Age greater than or equal to 18 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 days

Awards & highlights

Study Summary

This trial will study if a nerve block can help treat severe headache caused by aneurysmal subarachnoid hemorrhage, reducing the need for opioid painkillers.

Who is the study for?

This trial is for adults over 18 with a secured brain aneurysm who've had a subarachnoid hemorrhage and can communicate their pain level. It's not for those allergic to local anesthetics like bupivacaine, have unsecured aneurysms, or can't express pain due to sedation or other conditions.Check my eligibility

What is being tested?

The study tests if a nerve block in the pterygopalatine fossa using Bupivacaine can manage severe headaches caused by subarachnoid hemorrhage and reduce the need for opioids that often lead to dependence.See study design

What are the potential side effects?

Possible side effects of the PPF block may include discomfort at injection site, infection risk, bleeding, numbness beyond the target area, and allergic reactions to Bupivacaine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had a bleeding in the brain from a treated aneurysm.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Opioid consumption

Pain Rating Scale

Trial Design

1Treatment groups

Experimental Treatment

Group I: Treatment armExperimental Treatment2 Interventions

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Bupivacaine 0.25% Injectable Solution

2018

Completed Phase 4

~910

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,048 Previous Clinical Trials

1,053,725 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total number of participants currently enrolled in this investigation?

"Affirmative. Clinicaltrials.gov divulges that this trial is actively accepting participants with the initial annoucement of posting dated on November 6th 2023 and most recent update occurring on November 3rd 232023. The study requires 10 individuals to be enrolled from 1 medical site."

Answered by AI

Are opportunities available to join this investigation currently?

"The clinical trial registry on ClinicalTrials.gov verifies that the medical study is currently enrolling participants. This research project was initiated in November 6th 2023 and was revised most recently on November 3rd of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage

Noah Jouett 2023. "Pterygopalatine Fossa Block in Aneurysmal Subarachnoid Hemorrhage". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05925478.

All > Sah